Insider filing · VCYT
Phillip G. Febbo
Chief Scientific & Med Officer
profile →
Veracyte, Inc.
VCYT · Healthcare · 50 filings in 24 months
ticker →
Phillip G. Febbo sold $268K of Veracyte (VCYT)
Executed Mar 4 2025, disclosed Mar 6 2025, 2 days later.
Value, as filed
$268K
8,037 sh across 2 lots
Executed
Mar 4 2025
the trade date, as filed
Disclosed
Mar 6 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
PFPhillip G. Febbo (Chief Scientific & Med Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Veracyte, Inc. (VCYT). The largest single filing was $564K of VCYT (13,110 sh across 2 lots, as filed), executed Sep 4.
The name
VCYTHealthcare · Veracyte, Inc. operates as a diagnostics company in the United States and internationally
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Phillip G. Febbo in VCYT
VCYTSALE
Veracyte, Inc.
$564K13,110 sh across 2 lots
Exec Sep 4
Filed Sep 4 · 7:54 PM ET VCYTSALE Veracyte, Inc. $485K
13,425 sh × $36.16
Exec Mar 2
Filed Mar 4 · 5:30 PM ET VCYTSALE Veracyte, Inc. $301K
8,349 sh × $36.02
Exec Oct 6 2025
Filed Oct 7 2025 · 5:30 PM ET VCYTSALE Veracyte, Inc. $173K
3,934 sh × $44.09
Exec Dec 4 2024
Filed Dec 6 2024 · 5:30 PM ET